Gui-Fang Guo (Guifang Guo)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Locally Advanced

Metastatic Colorectal Cancer

Systematic Review

Top Venues

European journal of clinical pharmacology

Evidence-based complementary and alternative medicine : eCAM

Cancer medicine

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jinsheng Huang, Xujia Li, Qi Jiang, Huijuan Qiu, Yuming Rong, Bokang Cui, Gui-Fang Guo
Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for Survival. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Jinsheng Huang, Xujia Li, Jicheng Hong, Lingli Huang, Qi Jiang, Shunqi Guo, Yuming Rong, Gui-Fang Guo
Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations. Cancer medicine (2023)
Jinsheng Huang, Xujia Li, Qi Jiang, Huijuan Qiu, Yuming Rong, Bokang Cui, Gui-Fang Guo
Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for Survival. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Xujia Li, Jinsheng Huang, Fenghua Wang, Qi Jiang, Lingli Huang, Shengping Li, Gui-Fang Guo
Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer. Therapeutic advances in medical oncology 15 (2023)
Jin Sheng Huang, Jun Kan, Teng Fan, Qi Quan, Xujia Li, Qi Jiang, Bei Zhang, Gui-Fang Guo
Efficacy of the Nourishing Yin and Clearing Heat Therapy Based on Traditional Chinese Medicine in the Prevention and Treatment of Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinomas: A Systematic Review and Meta-Analysis of Thirty Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Xujia Li, Jinsheng Huang, Chang Jiang, Ping Chen, Qi Quan, Qi Jiang, Shengping Li, Gui-Fang Guo
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis. European journal of clinical pharmacology 79 (3) (2022)
Xujia Li, Jinsheng Huang, Chang Jiang, Ping Chen, Qi Quan, Qi Jiang, Shengping Li, Gui-Fang Guo
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis. European journal of clinical pharmacology 79 (3) (2022)
Wen-Zhuo He, Lei Wang, Chen-Xi Yin, Jia-Hong Yi, Ya-Nan Jin, Chang Jiang, Gui-Fang Guo, Liang-Ping Xia
Regorafenib with or without a programmed cell death protein 1 antibody as third-line treatment for microsatellite stable metastatic colorectal cancer. Cancer medicine (2022)
Xujia Li, Jinsheng Huang, Chang Jiang, Ping Chen, Qi Quan, Qi Jiang, Shengping Li, Gui-Fang Guo
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis. European journal of clinical pharmacology (2022)
Xujia Li, Jinsheng Huang, Chang Jiang, Ping Chen, Qi Quan, Qi Jiang, Shengping Li, Gui-Fang Guo
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis. European journal of clinical pharmacology 79 (3) (2022)